Sex differences in Alzheimer’s disease and common neuropathologies of aging
Open accessAbstract
Alzheimer’s dementia is significantly more common in women than in men. However, few pathological studies have addressed sex difference in Alzheimer’s disease (AD) and other brain pathologies. We leveraged postmortem data from 1453 persons who participated in one of two longitudinal community-based studies of older adults, the Religious Orders Study and the Rush Memory and Aging Project. Postmortem examination identified AD pathologies, neocortical Lewy bodies, DNA-binding protein 43 (TDP-43), hippocampal sclerosis, gross and micro infarcts, atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy. Linear and logistic regressions examined the association of sex with each of the pathologic measures. Two-thirds of subjects were women (n = 971; 67%), with a mean age at death of 89.8 (SD = 6.6) years in women and 87.3 (SD = 6.6) in men. Adjusted for age and education, women had higher levels on a global measure of AD pathology (estimate = 0.102, SE = 0.022, p < 0.001), and tau tangle density in particular (estimate = 0.334, SE = 0.074, p < 0.001), and there was a borderline difference between women and men in amyloid-β load (estimate = 0.124, SE = 0.065, p = 0.056). In addition, compared to men, women were more likely to have more severe arteriolosclerosis (OR = 1.28, 95% CI:1.04–1.58, p = 0.018), and less likely to have gross infarcts (OR = 0.78, 95% CI:0.61–0.98, p = 0.037), although the association with gross infarct was attenuated after controlling for vascular risk factors. These data help elucidate the neuropathologic footprint of sex difference in AD and other common brain pathologies of aging.
AI snapshot
Written from the paper’s full text.
TL;DR
In 1,453 autopsies from two community-based aging cohorts, women had more Alzheimer’s disease (AD) pathology, especially tau tangle density, and more severe arteriolosclerosis than men. These differences were not explained by age, APOE ε4, menopause type, or hormone replacement therapy.
Key findings
- Among 1,453 deceased participants (971 women, 67%; mean age at death 89.8 years in women vs. 87.3 in men), women had higher global AD pathology after adjustment for age and education (estimate=0.102, SE=0.022, p<0.001) and higher tau tangle density (estimate=0.334, SE=0.074, p<0.001); Aβ load was borderline (estimate=0.124, SE=0.065, p=0.056).
- More than 60% met pathologic criteria for AD, with a higher percentage in women (68%) than men (58%); women were 35% more likely to have a pathologic AD diagnosis (OR=1.35, 95% CI:1.06–1.72).
- Women were more likely to have severe arteriolosclerosis (OR=1.28, 95% CI:1.04–1.58, p=0.018) and less likely to have gross infarcts (OR=0.78, 95% CI:0.61–0.98, p=0.037), though the gross infarct association attenuated after controlling for vascular risk factors (OR=0.80, 95% CI:0.63–1.02, p=0.072).
- No sex differences were found for neocortical Lewy bodies, TDP-43, hippocampal sclerosis, microinfarcts, atherosclerosis, or cerebral amyloid angiopathy; no interaction was found between sex and APOE ε4, and both natural- and surgical-menopause women had higher AD pathology than men.
Methods
- Cross-sectional postmortem analysis of 1,453 participants from the Religious Orders Study and Rush Memory and Aging Project, two longitudinal community-based cohorts of older adults without dementia at entry; follow-up exceeded 90% and autopsy rate exceeded 85%.
- Neuropathologic evaluation included immunohistochemistry and stereology for tau tangle density and Aβ load across 8 cortical regions, a global AD pathology score from Bielschowsky silver-stained neuritic plaques, diffuse plaques, and neurofibrillary tangles, plus assessments of Lewy bodies, TDP-43, hippocampal sclerosis, infarcts, atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy.
- Linear and logistic regressions adjusted for age and education examined sex associations, with additional models for age and APOE ε4 interactions, menopause type/age, hormone replacement therapy, vascular risk factors, and cohort; analyses used SAS version 9.4.
Limitations
- The paper states participants had higher education levels and more than 95% were Caucasian, reducing generalizability; tau measures described only neuronal, not astrocytic, tau burden and lacked aging-related tau astrogliopathy data; contribution of primary age-related tauopathy or AD subtypes was unknown; only single-epitope fibrillary Aβ and helical filament tau were quantified; and autopsy was limited to one hemisphere.
- Evident from the text: the cross-sectional autopsy design cannot establish causality or temporal ordering, and the cohort composition may limit generalizability to more diverse or clinically referred populations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
20 of 42 cited sources checked · 13 supported · 3 flagged · accuracy not yet measured
- Premisecitation
Two studies that reported different sex-AD pathology association in different ages did not utilize statistical interaction modeling.
“Likewise, two studies that reported different sex-AD pathology association in different ages did not utilize statistical interaction modeling [34,43].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [34] Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26:343–350 source
- cites [43] Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD et al (2010) Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol 257:1875–1881 source
The Results (page not provided) report a different sex–AD pathology association before and after age 80, but they also state that an age-by-diagnosis interaction was assessed in a separate logistic model. That directly contradicts the claim that this study did not use statistical interaction modeling; the interaction was not significant. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Study design and conductreasoning
The two cohorts (ROS and MAP) used uniform data collection, making it feasible to combine data across them to examine associations of clinical data with brain pathologies.
“With uniform data collection, it is feasible to combine data across the two cohorts to examine associations of clinical data with brain pathologies, as done in many of our prior studies [4,45].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [4] Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA (2016) Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol 15:934–943 source
- cites [45] Oveisgharan S, Buchman AS, Yu L, Farfel J, Hachinski V, Gaiteri C et al (2018) APOE epsilon2epsilon4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology 92(24):e2127–e2134 source
- Premisecitation
Clinical longitudinal studies have shown susceptibility of women with surgical menopause at young ages to cognitive decline and dementia.
“Yet, clinical longitudinal studies have shown susceptibility of women with surgical menopause at young ages to cognitive decline [14] and dementia [52].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [14] Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA et al (2014) Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82:222–229 source
- cites [52] Rocca WA, Grossardt BR, Shuster LT, Stewart EA (2012) Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener Dis 10:175–178 source
- Premisecitation
In a previous study, younger age at onset of menopause among women with surgical, not natural, menopause was associated with more AD pathologies.
“In our previous study, we found that younger age at onset of menopause among women with surgical, not natural, menopause was associated with more AD pathologies [14].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [14] Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA et al (2014) Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82:222–229 source
- Premisecitation
Few if any previous studies that investigated the association of sex with AD pathologies have examined menopausal factors.
“Few if any of the previous studies which investigated the association of sex with AD pathologies have examined menopausal factors [25,41,43,53].”
Quote in the paperNot a substantial claim2 of 4 sources checked- cites [25] Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B et al (2018) Sex-specific association of apolipoprotein E With cerebrospinal fluid levels of Tau. JAMA Neurol 75(8):989–998 source
The Introduction describes prior research on sex differences in APOE-associated Alzheimer’s pathology, and the Discussion proposes hormonal changes around menopause as a possible mechanism. Neither passage says whether few, if any, previous studies examined menopausal factors. Searches for menopausal status and hormone measures did not establish that claim. (LLM, conf=0.72)
Experimental — accuracy not yet measured - cites [41] Miller FD, Hicks SP, D’Amato CJ, Landis JR (1984) A descriptive study of neuritic plaques and neurofibrillary tangles in an autopsy population. AmJ Epidemiol 120:331–341 source
- cites [43] Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD et al (2010) Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol 257:1875–1881 source
The Introduction and Discussion discuss sex hormones as possible influences on neurodegenerative disease, but do not assess whether previous studies of sex and AD pathology examined menopausal factors. A search for menopause, postmenopausal status, and related factors found only a postmenopausal-estrogen study in the References, not a statement supporting the claimed assessment of prior studies. (LLM, conf=0.73)
Experimental — accuracy not yet measured - cites [53] Sandberg G, Stewart W, Smialek J, Troncoso JC (2001) The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender. Neurobiol Aging 22:169–175 source
- Premisecitation
Arteriolosclerosis is associated with AD dementia.
“given the association of arteriolosclerosis with AD dementia [4].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA (2016) Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol 15:934–943 source
- Premisecitation
In animal experiments, bilaterally ovariectomized rats developed Aβ 1−42 in the hippocampus after exposure to stress.
“In animal experiments, bilaterally ovariectomized rats developed Aβ 1 −42 in the hippocampus after exposure to stress, a finding which corroborate with our finding of more Aβ in women with surgical menopause at young ages [59,66].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [59] Scott EL, Zhang QG, Vadlamudi RK, Brann DW (2014) Premature menopause and risk of neurological disease: basic mechanisms and clinical implications. Mol Cell Endocrinol 389:2–6 source
Section 3.1 reports increased hippocampal amyloidogenesis in surgically menopausal rats after ischemic stress. It separately says their hippocampus was more sensitive to the neurotoxic effects of Aβ1-42; it does not establish that the stress caused the rats to develop that specific peptide. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [66] Zhang QG, Wang RM, Scott E, Han D, Dong Y, Tu JY et al (2013) Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause. Brain 136:1432–1445 source
- Findingown data
There was no interaction between APOE ε4 and sex in the association with AD pathology.
“There was no interaction, suggesting that our finding of higher AD pathology in women compared to men did not vary by the APOE ε4 status.”
Quote in the paperSubstantial claim - Findingown data
The interaction between sex and categorical age was non-significant.
“When we added to the predictors a term for an interaction between sex and the categorical age we found the interaction to be non-significant (Table 3)”
Quote in the paperSubstantial claim - Findingown data
Compared to men, women were more likely to have more severe arteriolosclerosis (OR=1.28, 95% CI:1.04-1.58, p=0.018).
“In addition, compared to men, women were more likely to have more severe arteriolosclerosis (OR=1.28, 95% CI:1.04–1.58, p=0.018)”
Quote in the paperNot a substantial claim - Findingown data
There was an interaction between age and sex in the association with the global AD pathologic score (estimate=−0.008, SE=0.003, p=0.023).
“After adding a term for the interaction between age and sex to the linear regression models, we observed an interaction in the association with the global AD pathologic score outcome (estimate=−0.008, SE=0.003, p=0.023) (Table 2).”
Quote in the paperNot a substantial claim - Findingown data
Adjusted for age and education, women had higher levels on a global measure of AD pathology than men (estimate=0.102, SE=0.022, p<0.001).
“Adjusted for age and education, women had higher levels on a global measure of AD pathology (estimate=0.102, SE=0.022, p<0.001)”
- Also stated in: § AD pathology · plain
“Controlling for age and education, women had a higher AD pathologic score compared to men (estimate=0.102, SE=0.022, p<0.001) (Figure 1).”
Quote in the paperSubstantial claim - Also stated in: § AD pathology · plain
- Findingown data
After controlling for age, education, and cohorts, women had more amyloid (estimate=0.139, SE=0.064, p=0.031).
“but changed the amyloid’s association: women had more amyloid when we controlled for age, education, and the cohorts (estimate=0.139, SE=0.064, p=0.031) (Supplemental Table e-4).”
Quote in the paperSubstantial claim - Findingown data
After controlling for age and education, women were 35% more likely to have a pathologic diagnosis of AD (OR=1.35, 95% CI:1.06-1.72).
“After controlling for age and education, women were 35% more likely to have a pathologic diagnosis of AD (OR=1.35, 95% CI:1.06–1.72).”
Quote in the paperSubstantial claim - Findingown data
There was no significant interaction between sex and age in their association with tau tangles or Aβ.
“But, we did not find a significant interaction between sex and age in their association with tau tangles or Aβ (Table 2).”
Quote in the paperSubstantial claim - Findingown data
Adjusted for age and education, there was a borderline difference between women and men in amyloid-β load (estimate=0.124, SE=0.065, p=0.056).
“and there was a borderline difference between women and men in amyloid-β load (estimate=0.124, SE=0.065, p=0.056).”
- Also stated in: § AD pathology · plain
“Although women had a higher Aβ load than men (p<0.001), the difference was borderline significant after controlling for age and education (estimate=0.124, SE=0.065, p=0.056) (Figure 1).”
Quote in the paperNot a substantial claim - Also stated in: § AD pathology · plain
- Findingown data
Adjusted for age and education, women had higher tau tangle density than men (estimate=0.334, SE=0.074, p<0.001).
“and tau tangle density in particular (estimate=0.334, SE=0.074, p<0.001)”
- Also stated in: § AD pathology · plain
“Compared to men, women had a higher tau tangle density which remained after controlling for age and education (estimate=0.334, SE=0.074, p<0.001) (Figure 1).”
Quote in the paperSubstantial claim - Also stated in: § AD pathology · plain
- Findingreasoning
Women had less gross infarcts compared to men.
“In contrast to arteriolosclerosis, women had less gross infarcts compared to men.”
Quote in the paperNot a substantial claim - Findingown data
The difference between women and men in Aβ load was borderline significant.
“While the difference between women and men in Aβ load was borderline significant, women with surgical menopause at younger ages had more Aβ compared to men.”
Quote in the paperNot a substantial claim - Findingown data
Women have more tau tangles compared to men.
“In conclusion, we found women to have more AD pathology, tau tangles in particular, and arteriolosclerosis compared to men that helps elucidate the neuropathologic footprint of sex difference in AD dementia.”
Quote in the paperSubstantial claim - Findingcitation
The authors' study found no interaction between sex and APOE ε4 on AD pathology.
“Like ours, a recent study, composed of 8 data sets of clinical-pathologic studies, including our studies reported here, reported no interaction between sex and APOE ε4 on AD pathology [25].”
Quote in the paperSubstantial claim - Findingown data
Women with surgical menopause at younger ages had more Aβ compared to men.
“While the difference between women and men in Aβ load was borderline significant, women with surgical menopause at younger ages had more Aβ compared to men.”
Quote in the paperNot a substantial claim - Findingown data
HRT use was not associated with AD pathology.
“In separate analysis, we found that HRT use was not associated with AD pathology.”
Quote in the paperSubstantial claim - Findingown data
Sex was significantly associated with arteriolosclerosis.
“We found significant associations with gross infarcts and arteriolosclerosis.”
Quote in the paperSubstantial claim - Findingnone given
The association of age with AD pathology was not linear.
“when we took account a finding that the association of age with AD pathology was not linear.”
Quote in the paperSubstantial claim - Findingown data
The association of sex with arteriolosclerosis did not change after controlling for vascular risk factors and diseases.
“when we controlled for vascular risk factors and diseases the association of sex with arteriolosclerosis did not change.”
Quote in the paperSubstantial claim - Findingown data
The authors found an interaction between sex and age with the global AD pathologic score.
“We did not find an interaction between sex and age in their association with the tau tangles and the Aβ load, but found an interaction with the global AD pathologic score.”
Quote in the paperNot a substantial claim - Findingown data
The sex-by-age interaction with the global AD pathologic score was attenuated and no longer significant when accounting for the non-linear association of age with AD pathology.
“However, this interaction was attenuated and no longer significant when we took account a finding that the association of age with AD pathology was not linear.”
Quote in the paperSubstantial claim - Findingown data
In this study, surgically menopaused women have higher AD pathologies compared to men irrespective of age of menopause.
“In this study, we found that surgically menopaused women have higher AD pathologies compared to men irrespective of age of menopause.”
Quote in the paperSubstantial claim - Findingown data
The authors found no interaction between sex and age in their association with tau tangles and Aβ load.
“We did not find an interaction between sex and age in their association with the tau tangles and the Aβ load, but found an interaction with the global AD pathologic score.”
Quote in the paperSubstantial claim - Findingown data
The association between sex and gross infarcts was attenuated and no longer significant after controlling for vascular risk factors.
“given that the association was attenuated and no longer significant after controlling for vascular risk factors.”
Quote in the paperSubstantial claim - Findingown data
Sex was significantly associated with gross infarcts.
“We found significant associations with gross infarcts and arteriolosclerosis.”
Quote in the paperSubstantial claim - Findingown data
Women's brains had more severe arteriolosclerosis than men's.
“We found women’s brain to have more severe arteriolosclerosis, which may at least partially explain the higher prevalence of AD dementia in women given the association of arteriolosclerosis with AD dementia [4].”
Quote in the paperSubstantial claim - Interpretationown data
The tau tangle density among women was equivalent to that among men who were 13 years older.
“This was equivalent to men who were 13 years older.”
Quote in the paperSubstantial claim - Premisecitation
Alzheimer's dementia is significantly more common in women than in men.
“Alzheimer’s dementia is significantly more common in women than in men.”
- Also stated in: § INTRODUCTION · plain
“Alzheimer’s dementia is significantly more common in women than in men.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Association Alzheimer’s (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 12:459–509 source
- Also stated in: § INTRODUCTION · plain
- Interpretationreasoning
The global AD score among women was equivalent to that among men who were 12 years older.
“global AD score among women were equivalent to that among men who were 12 years older.”
Quote in the paperSubstantial claim - Study design and conductcitation
The inter-rater reliability of the counts of AD pathologic indices was 0.89 to 0.93, supporting reproducibility.
“In our previous study, we found that the inter-rater reliability of the counts of AD pathologic indices were from 0.89 to 0.93, supporting reproducibility of these measures [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE et al (2003) Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer’s disease. Neurology 60:246–252 source
- Study design and conductown data
Controlling for cohort did not change the association of tangles with sex.
“Controlling for the participants’ cohort in our model did not change the association of tangles with sex”
Quote in the paperNot a substantial claim - Interpretationreasoning
Women had higher load of AD pathology compared to men irrespective of their age at death.
“implicating women had higher load of AD pathology compared to men irrespective of their age at death.”
Quote in the paperSubstantial claim - Study design and conductown data
Controlling for cohort did not change the association of sex with global AD score.
“In further analyses, we added a term representing the two cohorts to the models’ predictors, and the association of sex with the global AD score did not change (Supplemental Table e-4).”
Quote in the paperNot a substantial claim - Study design and conductown data
Adding vascular risk factors and their duration or vascular diseases to the core models did not change the results.
“Then, we examined addition of vascular risk factors and their duration or vascular diseases to the core models and the results did not change either (Supplemental Table e-7).”
Quote in the paperSubstantial claim - Premisecitation
Clinical studies have reported that women APOE ε4 carriers had a higher risk of Alzheimer's dementia than men carriers.
“Separately, clinical studies have reported that women APOE ε4 carriers had a higher risk of Alzheimer’s dementia than men carriers [21].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278:1349–1356 source
- Interpretationown data
The findings help elucidate the neuropathologic footprint of sex difference in AD dementia.
“In conclusion, we found women to have more AD pathology, tau tangles in particular, and arteriolosclerosis compared to men that helps elucidate the neuropathologic footprint of sex difference in AD dementia.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The findings are more generalizable than studies from memory or other clinics or brain banks of confirmed AD dementia subjects.
“Further, our findings are more generalizable than studies from memory or other clinics or brain banks of confirmed AD dementia subjects.”
Quote in the paperSubstantial claim - Interpretationown data
Type of menopause cannot account for the sex difference in AD pathology.
“This suggests that type of menopause can not account for the sex difference in AD pathology.”
Quote in the paperSubstantial claim - Study design and conductown data
Restricting analyses to non-Latino whites (n=1377) left results essentially unchanged.
“We repeated the above analyses by restricting to non-Latino whites (n=1377) and results were essentially unchanged (data not shown).”
Quote in the paperNot a substantial claim - Premisecitation
Mixed dementia, not "pure" AD, is the most common cause of dementia in the community.
“Mixed dementia, not “pure” AD, is the most common cause of dementia in the community [31,56].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31] Jellinger KA, Attems J (2015) Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) 122:505–521 source
- cites [56] Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197–2204 source
- Interpretationown data
The finding of higher AD pathology in women compared to men did not vary by APOE ε4 status.
“suggesting that our finding of higher AD pathology in women compared to men did not vary by the APOE ε4 status.”
Quote in the paperSubstantial claim - Interpretationreasoning
Women had more AD pathologies compared to men independent of their age and APOE ε4 status.
“Therefore, women had more AD pathologies compared to men independent of their age and APOE ε4 status.”
Quote in the paperSubstantial claim - Interpretationreasoning
More severe arteriolosclerosis in women may at least partially explain the higher prevalence of AD dementia in women.
“We found women’s brain to have more severe arteriolosclerosis, which may at least partially explain the higher prevalence of AD dementia in women given the association of arteriolosclerosis with AD dementia [4].”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 24
- May combine two claims. 29
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe 4-stage classification of TDP-43 distribution was based on previous studies.
“In this study, we used a 4-stages classification of TDP-43 distribution based on previous studies [30,42]”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [30] James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA (2016) TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia. Brain 139:2983–2993 source
- cites [42] Nag S, Yu L, Capuano AW, Wilson RS, Leurgans SE, Bennett DA et al (2015) Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol 77:942–952 source
The Methods (Immunohistochemical studies) explicitly recognize three stages of TDP-43 distribution, not four. The paper says its assessment was described previously, but it does not support the attributed four-stage classification. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationOnly a few studies have directly investigated the association between sex and AD and other common neuropathologies, and these had small sample sizes (less than 200 brain autopsies) or did not examine pathologies other than AD.
“Yet, to date, only a few studies have directly investigated the association between sex and AD and other common neuropathologies. Further, these included only a small sample size (less than 200 brain autopsies) [41,53], or did not examine pathologies other than AD [41,43,53].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [41] Miller FD, Hicks SP, D’Amato CJ, Landis JR (1984) A descriptive study of neuritic plaques and neurofibrillary tangles in an autopsy population. AmJ Epidemiol 120:331–341 source
- cites [53] Sandberg G, Stewart W, Smialek J, Troncoso JC (2001) The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender. Neurobiol Aging 22:169–175 source
- cites [43] Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD et al (2010) Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol 257:1875–1881 source
The paper contradicts the characterization attributed to it. Its Abstract reports 3,830 autopsied subjects, and the Introduction says it tested associations between sex and AD, neocortical Lewy body, and mixed pathologies—not AD alone. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnother study reported that an AD pathologic diagnosis was more common among women in patients older than age 75 years.
“Further, another study reported that an AD pathologic diagnosis was more common among women in patients older than age 75 years [34].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [34] Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26:343–350 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCommon age-related neuropathologies, including Alzheimer's disease and other neurodegenerative and cerebrovascular pathologies, are the main causes of dementia, including Alzheimer's dementia.
“Common age-related neuropathologies, including Alzheimer’s disease (AD) and other neurodegenerative and cerebrovascular pathologies, are the main causes of dementia, including Alzheimer’s dementia [31,34].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [31] Jellinger KA, Attems J (2015) Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) 122:505–521 source
- cites [34] Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26:343–350 source
The Introduction says neurodegenerative diseases are the most common disorders underlying dementia, and the Results document AD, vascular pathology, and other diagnoses among people with dementia. The Influence of Age and Gender section reports that AD and combined diagnoses were more frequent in older patients. The paper does not establish that cerebrovascular pathology is among the main causes, or specifically assess the causes of clinically diagnosed Alzheimer’s dementia. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn prior work, women who had surgical menopause at an early age had a faster decline in cognitive function and more AD pathology at autopsy, and neuritic plaques in particular, compared to women with surgical menopause at older ages.
“In prior work, we found that women, a subset of those in the current study, who had surgical menopause at an early age had a faster decline in cognitive function and more AD pathology at autopsy, and neuritic plaques in particular, compared to women with surgical menopause at older ages [14].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [14] Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA et al (2014) Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82:222–229 source
May combine two claims.
PremisecitationOne clinical-pathologic study reported that the odds of AD pathology was not different between women and men if they were younger than 80 years at death, but women older than 80 years had a higher odds of AD pathology compared to men.
“One clinical-pathologic study reported that the odds of AD pathology was not different between women and men if they were younger than 80 years at death, but women older than 80 years had a higher odds of AD pathology compared to men [43].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [43] Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD et al (2010) Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol 257:1875–1881 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVascular risk factors like higher blood pressure levels are associated with cerebral vessel disease including arteriolosclerosis.
“while vascular risk factors like higher blood pressure levels have been found associated with cerebral vessel disease including arteriolosclerosis [28,3]”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [28] Ighodaro ET, Abner EL, Fardo DW, Lin AL, Katsumata Y, Schmitt FA et al (2017) Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab 37:201–216 source
- cites [3] Arvanitakis Z, Capuano AW, Lamar M, Shah RC, Barnes LL, Bennett DA et al (2018) Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. https://doi.org/10.1212/wnl.0000000000005951 source
May combine two claims.
Findingown dataMore than 60% of all autopsied participants met criteria for a pathologic diagnosis of AD, and the percentage was higher among women (68%) than men (58%) (p<0.001).
“More than 60% of all autopsied participants met criteria for a pathologic diagnosis of AD, and the percentage was higher among women (68%) than men (58%) (p<0.001).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataParticipants older than 90 were not different from participants aged 80-90 years in global AD pathologic scores (p=0.238), but both groups had higher scores than participants younger than 80 (both p<0.001), indicating a non-linear relationship between age and AD pathology.
“However, participants older than 90 were not different from participants aged 80–90 years (p = 0.238) although both groups had higher global AD pathologic scores than participants younger than 80 (both p < 0.001), indicating a non-linear relationship between age and AD pathology.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCompared to men, women were less likely to have gross infarcts (OR=0.78, 95% CI:0.61-0.98, p=0.037), although the association was attenuated after controlling for vascular risk factors.
“and less likely to have gross infarcts (OR=0.78, 95% CI:0.61–0.98, p=0.037), although the association with gross infarct was attenuated after controlling for vascular risk factors.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWomen had higher levels of tangles in both mesial temporal and neocortical regions, but had higher levels of amyloid only in the mesial temporal.
“Women had higher levels of tangles in both mesial temporal and neocortical regions, but had higher levels of amyloid only in the mesial temporal.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWomen were about 3 years older than men (p<0.001), had one year less of education (p<0.001), and had fewer vascular risk factors (p<0.001).
“Women were about 3 years older than men (p<0.001), had one year less of education (p<0.001), and had fewer vascular risk factors (p<0.001).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataHRT was used by nearly 40% (n=397) of women in their life, was more frequently used by women with surgical than natural menopause (59% vs. 33%, p<0.001), and was in the oral dosing formulation in 93% of women.
“HRT was used by nearly 40% (n=397) of women in their life, was more frequently used by women with surgical than natural menopause (59% vs. 33%, p<0.001), and was in the oral dosing formulation in 93% of women.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth women with natural menopause and women with surgical menopause have higher levels of AD pathologies compared to men.
“We found that both women with natural and those with surgical menopause have higher levels of AD pathologies compared to men.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAbout a third of women (n=306, 32%) reported having been exposed to surgical menopause, and menopause was induced by hysterectomy in 95% of cases.
“About a third of women (n=306, 32%) reported having been exposed to surgical menopause, and menopause was induced by hysterectomy in 95% of cases.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere was no sex difference in APOE ε4 status (p=0.844), Alzheimer's dementia (p=0.099), or vascular diseases burden (p=0.633).
“We did not observe any sex difference in the APOE ε4 status (p=0.844), Alzheimer’s dementia (p=0.099), or vascular diseases burden (p=0.633).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCompared to women with natural menopause, women with surgical menopause were younger at menopause (43.4±7.7 vs.48.8±5.5, p<0.001), but were not different at age of death (89.6±6.3 vs. 90.0±6.7, p=0.350) or years of education (15.7±3.4 vs. 15.9±3.3, p=0.458).
“Compared to women with natural menopause, women with surgical menopause were younger at menopause (43.4±7.7 vs.48.8±5.5, p<0.001), as expected, but were not different at age of death (89.6±6.3 vs. 90.0±6.7, p=0.350) or years of education (15.7±3.4 vs. 15.9±3.3, p=0.458).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn ROS, 93% of deceased participants had an autopsy.
“Of 732 (93%) who had an autopsy”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe overall follow-up rate of both cohorts exceeds 90%, and the autopsy rate exceeds 85%.
“The overall follow-up rate of both cohorts exceeds 90%, and the autopsy rate exceeds 85%.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationIn earlier work, women had more AD pathology and neurofibrillary tangles in particular, but not neuritic or diffuse plaques, among 141 subjects who came to autopsy.
“Also, in earlier work, we found that women had more AD pathology and neurofibrillary tangles in particular, but not neuritic or diffuse plaques, among 141 subjects who came to autopsy [8].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62:685–691 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAnother study reported that the association of APOE ε4 with neurofibrillary tangles was weaker in men than in women, while the association with senile plaques was significant in both sexes.
“and another study reported that the association of APOE ε4 with neurofibrillary tangles was weaker in men than in women, while the association with senile plaques was significant in both sexes [24].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Ghebremedhin E, Schultz C, Thal DR, Rub U, Ohm TG, Braak E et al (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56:1696–1701 source
May combine two claims.
Study design and conductcitationThe regional standardized scores were highly correlated with the global AD pathology score (r range 0.47-0.73, median 0.67) and Chronbach α 0.90, supporting use of the global AD pathology score.
“In our previous study, we showed that the regional standardized scores were highly correlated with the global AD pathology score (r range: 0.47–0.73, median r = 0.67) and the Chronbach α coefficient was 0.90, indicating high internal consistency and supporting use of the global AD pathology score [13].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE et al (2003) Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer’s disease. Neurology 60:246–252 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOne autopsy study found that women had more senile plaques, and the association was stronger among ε4 carriers.
“One autopsy study found that women had more senile plaques, and the association was stronger among ε4 carriers [17]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24–28 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe dichotomous summary variable for neocortical-type Lewy body pathology was previously shown to be associated with dementia.
“In this study, a dichotomous summary variable was used indicative of presence or absence of neocortical-type Lewy body pathology which we previously showed to be associated with dementia [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA (2012) Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain 135:3005–3014 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOf the estimated 5.2 million people with Alzheimer's dementia in the United States, 3.3 million are women and 1.9 million are men.
“Of the estimated 5.2 million people with Alzheimer’s dementia in the United States, 3.3 million are women and 1.9 million are men [2].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Association Alzheimer’s (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 12:459–509 source
May combine two claims.
Study design and conductcitationThe summary measures of tau tangle density and Aβ load were reliable and internally consistent, with Chronbach α 0.84 for tangles and 0.88 for Aβ.
“In our previous paper, we showed these summary measures to be reliable and internally consistent [11]. The Chronbach α coefficient was 0.84 for the tangles densities and 0.88 for the Aβ loads, showing high item (regions’ measures) total (summary measures) correlations.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61:378–384 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataDNA genotyping was performed by investigators blinded to all clinical and pathological data.
“DNA genotyping was performed at Polymorphic DNA Technologies (Alameda, CA) by investigators blinded to all clinical and pathological data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn MAP, 83% of deceased participants had an autopsy.
“of whom 756 (83%) had an autopsy”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationA board-certified neuropathologist, blinded to clinical data, determined the pathologic diagnosis of AD based on published criteria.
“In addition, a board-certified neuropathologist, blinded to clinical data, determined the pathologic diagnosis of AD based on published criteria [26].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenCore models were evaluated for violations of assumptions, by examining data both analytically and graphically.
“Core models were evaluated for violations of assumptions, by examining data both analytically and graphically.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataAdding terms for other common brain pathologies to the core models did not change the results: women had more AD pathology, specifically more tau tangles density.
“We added terms for other common brain pathologies to the predictors of the core models, and the results did not change: women had more AD pathology, specifically more tau tangles density (Supplemental Table e-6).”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataParticipants had higher levels of education and more than 95% were Caucasians, reducing generalizability to other populations.
“Participants had higher levels of education and more than 95% were Caucasians, reducing generalizability to other populations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningMore advanced statistical methods and larger samples may explain the discrepant results among recent and prior studies.
“More advanced statistical methods and larger samples may explain the discrepant results among recent and prior studies.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenNeuropathological evaluations were conducted blinded to clinical data.
“Finally, the two studies have uniform and structured procedures, and neuropathological evaluations are conducted blinded to clinical data.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe authors do not know how much of their tangle finding was driven by primary age-related tauopathy (PART), or what subtypes of AD account for most of the variance in the association of sex with the AD pathologic indices.
“Also, we do not know how much of our tangle finding was driven by the primary age-related tauopathy (PART), or what subtypes of AD, i.e. tangle-predominant form of AD, account for most of the variance in the association of sex with the AD pathologic indices.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTwo other studies reported differential associations between APOE ε4 and AD pathological indices in women and men, but they did not contain a formal interaction test between sex and APOE ε4.
“Although two other studies reported differential associations between APOE ε4 and AD pathological indices in women and men [17,24], they do not contain any formal interaction test between sex and APOE ε4.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [17] Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24–28 source
- cites [24] Ghebremedhin E, Schultz C, Thal DR, Rub U, Ohm TG, Braak E et al (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56:1696–1701 source
May combine two claims.
InterpretationreasoningTaken together, menopausal factors did not account for the higher AD pathology, and tau specifically, among women.
“Taken together, menopausal factors did not account for the higher AD pathology, and tau specifically, among women.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe authors currently do not have data on aging-related tau astriogliopathy (ARTAG).
“Our tau tangle density measure describes only neuronal, not astrocytic, tau tangle burden, and currently we do not have data on aging-related tau astriogliopathy (ARTAG).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe autopsy procedures were carried out on only one hemisphere, and pathologies restricted to the other hemisphere may be missed.
“Lastly, the autopsy procedures were carried out on only one hemisphere, and pathologies restricted to the other hemisphere may be missed.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenThe two studies have uniform and structured procedures.
“Finally, the two studies have uniform and structured procedures, and neuropathological evaluations are conducted blinded to clinical data.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe study included about 1500 brain autopsies of participants in one of two community-based longitudinal studies of ageing, with a large proportion of women allowing for comparison of women and men.
“It included about 1500 brain autopsies of participants in one of two community-based longitudinal studies of ageing, and with a large proportion of women allowing for comparison of women and men.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe authors only quantified the helical filament tau-positive tangles and the fibrillary form of Aβ by utilizing antibodies against single epitopes.
“Furthermore, we only quantified the helical filament tau-positive tangles and the fibrillary form of Aβ by utilizing antibodies against single epitopes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA recent meta-analysis of 58,000 participants showed that APOE ε3/ε4 women have the same increased odds of AD dementia as APOE ε3/ε4 men, whereas a previous meta-analysis reported APOE ε4 women to carry a higher risk of Alzheimer's dementia compared to APOE ε4 men.
“Furthermore, a recent meta-analysis of 58000 participants showed that APOE ε3/ε4 women have the same increased odds of AD dementia as APOE ε3ε4 men have, in contrast to a previous meta-analysis which reported APOE ε4 women to carry a higher risk of Alzheimer’s dementia compared to APOE ε4 men [21].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278:1349–1356 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe tau tangle density measure describes only neuronal, not astrocytic, tau tangle burden.
“Our tau tangle density measure describes only neuronal, not astrocytic, tau tangle burden, and currently we do not have data on aging-related tau astriogliopathy (ARTAG).”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe cohort studies have more than 90% follow up and about 85% autopsy rates, decreasing several sources of bias, including selection bias due to attrition.
“Also, the cohort studies have more than 90% follow up and about 85% autopsy rates, decreasing several sources of bias, including selection bias due to attrition.”
Quote in the paperSubstantial claim
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Women exhibit increased global Alzheimer's neuropathological burden and greater cognitive impairment compared to men.
“However, despite their prolonged survival, even with Alzheimer’s disease [7–9], women exhibit increased global Alzheimer’s neuropathological burden and greater cognitive impairment [10–13].”
From Age, sex and Alzheimer’s disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer’s patients (2024) · cites this paper as [13]
The Results (AD pathology; page unavailable) report a higher global AD pathology score in women than men, adjusted for age and education. The paper says AD dementia is more common in women and describes cognitive testing in Methods (Clinical evaluation; page unavailable), but the passages found do not establish that women had greater cognitive impairment than men. (LLM, conf=0.84)
Experimental — accuracy not yet measuredPost mortem studies indicate that females have lower resistance to AD pathologies.
“Moreover, post mortem studies indicate that females have lower resistance to AD pathologies. 70 , 71”
From Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes (2025) · cites this paper as [70]
Cites
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069 · see citing works
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069 · see citing works
Lee, J. A. H. (1986) · JAMA · doi:10.1001/jama.1986.03370120114036 · Cited by 2,252 · see citing works
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · see citing works
Self-citationHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542 · see citing works
Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260 · see citing works
Self-citationClinical epidemiology of Alzheimer&rsquo;s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021 · see citing works
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900 · see citing works
Individual differences in rates of change in cognitive abilities of older persons.
Wilson, R. S., Beckett, L. A., Barnes, L. L., Schneider, J. A., Bach, J., Evans, D. A., & Bennett, D. A. (2002) · Psychology and Aging · doi:10.1037/0882-7974.17.2.179 · Cited by 842 · see citing works
Self-citationRocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000276984.19542.e6 · Cited by 827 · see citing works
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765 · see citing works
Prevalence of mild cognitive impairment is higher in men
Petersen, R. C., Roberts, R. O., Knopman, D. S., Geda, Y. E., Cha, R. H., Pankratz, V. S., Boeve, B. F., Tangalos, E. G., Ivnik, R. J., & Rocca, W. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f11d85 · Cited by 738 · see citing works
Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
Barnes, L. L., Wilson, R. S., Bienias, J. L., Schneider, J. A., Evans, D. A., & Bennett, D. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.685 · Cited by 643 · see citing works
Self-citationArvanitakis, Z., Capuano, A. W., Leurgans, S. E., Bennett, D. A., & Schneider, J. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30029-1 · Cited by 581 · see citing works
Self-citationFratiglioni, L., Viitanen, M., von Strauss, E., Tontodonati, V., Herlitz, A., & Winblad, B. (1997) · Neurology · doi:10.1212/wnl.48.1.132 · Cited by 556 · see citing works
Bennett, D. A., Schneider, J. A., Wilson, R. S., Bienias, J. L., & Arnold, S. E. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.378 · Cited by 526 · see citing works
Self-citationSeshadri, S., Wolf, P. A., Beiser, A., Au, R., McNulty, K., White, R., & D'Agostino, R. B. (1997) · Neurology · doi:10.1212/wnl.49.6.1498 · Cited by 489 · see citing works
Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging
Kawas, C., Gray, S., Brookmeyer, R., Fozard, J., & Zonderman, A. (2000) · Neurology · doi:10.1212/wnl.54.11.2072 · Cited by 472 · see citing works
Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women
Bove, R., Secor, E., Chibnik, L. B., Barnes, L. L., Schneider, J. A., Bennett, D. A., & De Jager, P. L. (2014) · Neurology · doi:10.1212/wnl.0000000000000033 · Cited by 437 · see citing works
Self-citationLee, J., Cole, T. B., Palmiter, R. D., Suh, S. W., & Koh, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092034699 · Cited by 432 · see citing works
Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons
Boyle, P. A., Yu, L., Nag, S., Leurgans, S., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2015) · Neurology · doi:10.1212/wnl.0000000000002175 · Cited by 423 · see citing works
Self-citationTDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia
James, B. D., Wilson, R. S., Boyle, P. A., Trojanowski, J. Q., Bennett, D. A., & Schneider, J. A. (2016) · Brain · doi:10.1093/brain/aww224 · Cited by 407 · see citing works
Self-citationMicroinfarct Pathology, Dementia, and Cognitive Systems
Arvanitakis, Z., Leurgans, S. E., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2011) · Stroke · doi:10.1161/strokeaha.110.595082 · Cited by 404 · see citing works
Self-citationSex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau
Hohman, T. J., Dumitrescu, L., Barnes, L. L., Thambisetty, M., Beecham, G., Kunkle, B., Gifford, K. A., Bush, W. S., Chibnik, L. B., Mukherjee, S., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0821 · Cited by 340 · see citing works
Self-citationIncidence of AD may decline in the early 90s for men, later for women
Miech, R., Breitner, J., Zandi, P., Khachaturian, A., Anthony, J. C., & Mayer, L. D. (2002) · Neurology · doi:10.1212/wnl.58.2.209 · Cited by 339 · see citing works
Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's Disease
Reynolds, W. F., Rhees, J., Maciejewski, D. F., Paladino, T., Sieburg, H. B., Maki, R. A., & Masliah, E. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6977 · Cited by 321 · see citing works
Hippocampal sclerosis and <scp>TDP</scp> ‐43 pathology in aging and <scp>A</scp> lzheimer disease
Nag, S., Yu, L., Capuano, A. W., Wilson, R. S., Leurgans, S. E., Bennett, D. A., & Schneider, J. A. (2015) · Annals of Neurology · doi:10.1002/ana.24388 · Cited by 305 · see citing works
Self-citationRelation of cerebral infarctions to dementia and cognitive function in older persons
Schneider, J. A., Wilson, R. S., Cochran, E. J., Bienias, J. L., Arnold, S. E., Evans, D. A., & Bennett, D. A. (2003) · Neurology · doi:10.1212/01.wnl.0000055863.87435.b2 · Cited by 305 · see citing works
Self-citationRocca, W. A., Grossardt, B. R., & Shuster, L. T. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.031 · Cited by 283 · see citing works
Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer’s disease
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Aggarwal, N. T., Arnold, S. E., Cochran, E. J., Berry-Kravis, E., & Bienias, J. L. (2003) · Neurology · doi:10.1212/01.wnl.0000042478.08543.f7 · Cited by 282 · see citing works
Self-citationDiabetes is related to cerebral infarction but not to AD pathology in older persons
Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Li, Y., Arnold, S. E., Wang, Z., & Bennett, D. A. (2006) · Neurology · doi:10.1212/01.wnl.0000247053.45483.4e · Cited by 280 · see citing works
Self-citationCognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies
Schneider, J. A., Arvanitakis, Z., Yu, L., Boyle, P. A., Leurgans, S. E., & Bennett, D. A. (2012) · Brain · doi:10.1093/brain/aws234 · Cited by 273 · see citing works
Self-citationCORDER, E. H., GHEBREMEDHIN, E., TAYLOR, M. G., THAL, D. R., OHM, T. G., & BRAAK, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.005 · Cited by 254 · see citing works
Incidence of dementia and cognitive impairment, not dementia in the united states
Plassman, B. L., Langa, K. M., McCammon, R. J., Fisher, G. G., Potter, G. G., Burke, J. R., Steffens, D. C., Foster, N. L., Giordani, B., Unverzagt, F. W., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22362 · Cited by 250 · see citing works
TDP-43 Pathology, Cognitive Decline, and Dementia in Old Age
Wilson, R. S., Yu, L., Trojanowski, J. Q., Chen, E., Boyle, P. A., Bennett, D. A., & Schneider, J. A. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3961 · Cited by 248 · see citing works
Self-citationRelation of neuropathology to cognition in persons without cognitive impairment
Bennett, D. A., Wilson, R. S., Boyle, P. A., Buchman, A. S., & Schneider, J. A. (2012) · Annals of Neurology · doi:10.1002/ana.23654 · Cited by 220 · see citing works
Self-citationDementia From Alzheimer Disease and Mixed Pathologies in the Oldest Old
James, B. D. (2012) · JAMA · doi:10.1001/jama.2012.3556 · Cited by 199 · see citing works
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts
Arvanitakis, Z., Capuano, A. W., Leurgans, S. E., Buchman, A. S., Bennett, D. A. A., & Schneider, J. A. (2016) · Brain Pathology · doi:10.1111/bpa.12365 · Cited by 196 · see citing works
Self-citationMixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience
Kovacs, G. G., Alafuzoff, I., Al-Sarraj, S., Arzberger, T., Bogdanovic, N., Capellari, S., Ferrer, I., Gelpi, E., Kövari, V., Kretzschmar, H., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161560 · Cited by 186 · see citing works
Dementia and Alzheimer Disease Incidence Rates Do Not Vary by Sex in Rochester, Minn
Edland, S. D., Rocca, W. A., Petersen, R. C., Cha, R. H., & Kokmen, E. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1589 · Cited by 184 · see citing works
Gender, cognitive decline, and risk of AD in older persons
Barnes, L. L., Wilson, R. S., Schneider, J. A., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2003) · Neurology · doi:10.1212/01.wnl.0000065892.67099.2a · Cited by 173 · see citing works
Self-citationChallenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154 · see citing works
Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease
Rodríguez, M. Á. D. L. R., Silva, I., Nilsen, J., Pérez, M., García‐Segura, L. M., Ávila, J., & Naftolin, F. N. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.016 · Cited by 153 · see citing works
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
Filon, J. R., Intorcia, A. J., Sue, L. I., Vazquez Arreola, E., Wilson, J., Davis, K. J., Sabbagh, M. N., Belden, C. M., Caselli, R. J., Adler, C. H., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw047 · Cited by 143 · see citing works
Melnikova, T., Savonenko, A. V., Wang, Q., Liang, X., Hand, T. A., Wu, L., Kaufmann, W. E., Vehmas, A. K., & Andreasson, K. I. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.001 · Cited by 134 · see citing works
Association between male gender and cortical Lewy body pathology in large autopsy series
Nelson, P. T., Schmitt, F. A., Jicha, G. A., Kryscio, R. J., Abner, E. L., Smith, C. D., Van Eldik, L. J., & Markesbery, W. R. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5630-4 · Cited by 131 · see citing works
Devi, L., Alldred, M. J., Ginsberg, S. D., & Ohno, M. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-34 · Cited by 129 · see citing works
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 4× · see citing works
“Published clinical studies found that women had higher odds for Alzheimer’s dementia and this association was stronger among APOE ε4 carriers compared to ε3ε3 carriers [21].”
InfluentialHysterectomy, Oophorectomy, Estrogen, and the Risk of Dementia
Rocca, W. A., Grossardt, B. R., Shuster, L. T., & Stewart, E. A. (2012) · Neurodegenerative Diseases · doi:10.1159/000334764 · Cited by 122 · see citing works
Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology
Arvanitakis, Z., Capuano, A. W., Lamar, M., Shah, R. C., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2018) · Neurology · doi:10.1212/wnl.0000000000005951 · Cited by 112 · see citing works
Self-citationSex-specific genetic predictors of Alzheimer’s disease biomarkers
(ADNI), A. D. N. I., Deming, Y., The Alzheimer Disease Genetics Consortium (ADGC), Dumitrescu, L., Barnes, L. L., Thambisetty, M., Kunkle, B., Gifford, K. A., Bush, W. S., Chibnik, L. B., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1881-4 · Cited by 110 · see citing works
Gender and age modify the association between APOE and AD-related neuropathology
Ghebremedhin, E., Schultz, C., Thal, D. R., Rüb, U., Ohm, T. G., Braak, E., & Braak, H. (2001) · Neurology · doi:10.1212/wnl.56.12.1696 · Cited by 108 · see citing works
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals
Ighodaro, E. T., Abner, E. L., Fardo, D. W., Lin, A.-L., Katsumata, Y., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Neltner, J. H., Monsell, S. E., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621574 · Cited by 98 · see citing works
Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., Masters, C. L., Li, Q., & Bush, A. I. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.010 · Cited by 96 · see citing works
Placanica, L., Zhu, L., & Li, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005088 · Cited by 88 · see citing works
Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease
Congdon, E. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00372 · Cited by 81 · see citing works
TOMM40 ′523 variant and cognitive decline in older persons with APOE ε3/3 genotype
Yu, L., Lutz, M. W., Wilson, R. S., Burns, D. K., Roses, A. D., Saunders, A. M., Gaiteri, C., Jager, P. L. D., Barnes, L. L., & Bennett, D. A. (2017) · Neurology · doi:10.1212/wnl.0000000000003614 · Cited by 78 · see citing works
Self-citationDisentangling the effects of age and APOE on neuropathology and late life cognitive decline
Yu, L., Boyle, P. A., Leurgans, S., Schneider, J. A., & Bennett, D. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.074 · Cited by 71 · see citing works
Self-citationA DESCRIPTIVE STUDY OF NEURITIC PLAQUES AND NEUROFIBRILLARY TANGLES IN AN AUTOPSY POPULATION
DeWOLFE MILLER, F., HICKS, S. P., D'AMATO, C. J., & LANDIS, J. R. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113897 · Cited by 70 · see citing works
Sandberg, G., Stewart, W., Smialek, J., & Troncoso, J. C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00236-0 · Cited by 68 · see citing works
<i>APOE</i> ε2ε4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults
Oveisgharan, S., Buchman, A. S., Yu, L., Farfel, J., Hachinski, V., Gaiteri, C., De Jager, P. L., Schneider, J. A., & Bennett, D. A. (2018) · Neurology · doi:10.1212/wnl.0000000000005677 · Cited by 62 · see citing works
Self-citationGender dependent APP processing in a transgenic mouse model of Alzheimer’s disease
Schäfer, S., Wirths, O., Multhaup, G., & Bayer, T. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0580-9 · Cited by 52 · see citing works
Zhang, Q.-G., Wang, R.-M., Scott, E., Han, D., Dong, Y., Tu, J.-Y., Yang, F., Reddy Sareddy, G., Vadlamudi, R. K., & Brann, D. W. (2013) · Brain · doi:10.1093/brain/awt046 · Cited by 50 · see citing works
Premature menopause and risk of neurological disease: Basic mechanisms and clinical implications
Scott, E. L., Zhang, Q.-G., Vadlamudi, R. K., & Brann, D. W. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.013 · Cited by 36 · see citing works
Köglsberger, S., Cordero-Maldonado, M. L., Antony, P. M. A., Forster, J. I., Garcia, P., Buttini, M., Crawford, A. D., & Glaab, E. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0299-z · Cited by 36 · see citing works
Sex-dependent gene regulatory networks of the heart rhythm
Iacobaş, D. A., Iacobaş, S., Thomas, N., & Spray, D. C. (2009) · Functional & Integrative Genomics · doi:10.1007/s10142-009-0137-8 · Cited by 27 · see citing works
Oikawa, N., Ogino, K., Masumoto, T., Yamaguchi, H., & Yanagisawa, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.005 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz099 · Cited by 1,547 · see citing works
Self-citationBuckley, R. F., Mormino, E. C., Rabin, J. S., Hohman, T. J., Landau, S., Hanseeuw, B. J., Jacobs, H. I. L., Papp, K. V., Amariglio, R. E., Properzi, M. J., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4693 · Cited by 373 · see citing works
Mechanisms of sex differences in Alzheimer’s disease
Lopez-Lee, C., Torres, E. R. S., Carling, G., & Gan, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.01.024 · Cited by 376 · see citing works
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
Spina, S., La Joie, R., Petersen, C., Nolan, A. L., Cuevas, D., Cosme, C., Hepker, M., Hwang, J.-H., Miller, Z. A., Huang, E. J., et al. (2021) · Brain · doi:10.1093/brain/awab099 · Cited by 278 · see citing works
Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2023) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 306 · see citing works
Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation
Yang, L., Zhou, R., Tong, Y., Chen, P., Shen, Y., Miao, S., & Liu, X. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104814 · Cited by 249 · see citing works
Molecular pathology of neurodegenerative diseases: principles and practice
Kovács, G. G. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-205952 · Cited by 243 · see citing works
Sex and gender differences in cognitive resilience to aging and Alzheimer's disease
Arenaza‐Urquijo, E. M., Boyle, R., Casaletto, K., Anstey, K. J., Vila‐Castelar, C., Colverson, A., Palpatzis, E., Eissman, J. M., Kheng Siang Ng, T., Raghavan, S., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13844 · Cited by 223 · see citing works
Blevins, B. L., Vinters, H. V., Love, S., Wilcock, D. M., Grinberg, L. T., Schneider, J. A., Kalaria, R. N., Katsumata, Y., Gold, B. T., Wang, D. J. J., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02235-6 · Cited by 204 · see citing works
Self-citationMielke, M. M., Aggarwal, N. T., Vila‐Castelar, C., Agarwal, P., Arenaza‐Urquijo, E. M., Brett, B., Brugulat‐Serrat, A., DuBose, L. E., Eikelboom, W. S., Flatt, J., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12662 · Cited by 198 · see citing works
X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
Yan, Y., Wang, X., Chaput, D., Shin, M.-K., Koh, Y., Gan, L., Pieper, A. A., Woo, J.-A. A., & Kang, D. E. (2022) · Cell · doi:10.1016/j.cell.2022.09.002 · Cited by 144 · see citing works
Determining a multimodal aging clock in a cohort of Chinese women
Li, J., Xiong, M., Fu, X.-H., Fan, Y., Dong, C., Sun, X., Zheng, F., Wang, S., Liu, L., Xu, M., et al. (2023) · Med · doi:10.1016/j.medj.2023.06.010 · Cited by 148 · see citing works
Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline
Buckley, R. F., Scott, M. R., Jacobs, H. I. L., Schultz, A. P., Properzi, M. J., Amariglio, R. E., Hohman, T. J., Mayblyum, D. V., Rubinstein, Z. B., Manning, L. K., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25878 · Cited by 132 · see citing works
Redox signaling at the crossroads of human health and disease
Zuo, J., Zhang, Z., Luo, M., Zhou, L., Nice, E. C., Zhang, W., Wang, C., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.127 · Cited by 120 · see citing works
Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?
Kodama, L., & Gan, L. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.001 · Cited by 113 · see citing works
Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone
Sundermann, E. E., Panizzon, M. S., Chen, X., Andrews, M., Galasko, D. R., Banks, S. J., & Initiative, A. D. N. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00310-x · Cited by 102 · see citing works
Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress
Sumien, N., Cunningham, J. T., Davis, D., Engelland, R. E., Fadeyibi, O., Farmer, G. E., Mabry, S., Mensah-Kane, P., Trinh, O. T. P., Vann, P. H., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab185 · Cited by 102 · see citing works
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research
Dennison, J. L., Ricciardi, N. R., Lohse, I., Volmar, C., & Wahlestedt, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201014 · Cited by 100 · see citing works
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
Buckley, R. F., O’Donnell, A., McGrath, E. R., Jacobs, H. I. L., Lois, C., Satizábal, C. L., Ghosh, S., Rubinstein, Z. B., Murabito, J. M., Sperling, R. A., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26382 · Cited by 101 · see citing works
Tsiknia, A. A., Edland, S. D., Sundermann, E. E., Reas, E. T., Brewer, J. B., Galasko, D. R., Banks, S. J., & Initiative, A. D. N. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01675-8 · Cited by 98 · see citing works
Oveisgharan, S., Wilson, R. S., Yu, L., Schneider, J. A., & Bennett, D. A. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1941 · Cited by 88 · see citing works
Self-citationSex as an important factor in nanomedicine
Hajipour, M. J., Aghaverdi, H., Serpooshan, V., Vali, H., Sheibani, S., & Mahmoudi, M. (2021) · Nature Communications · doi:10.1038/s41467-021-23230-9 · Cited by 90 · see citing works
Sex-specific effects of microglial activation on Alzheimer’s disease proteinopathy in older adults
Casaletto, K. B., Nichols, E. L., Aslanyan, V., Simone, S. M., Rabin, J. S., Joie, R. L., Brickman, A. M., Dams-O’Connor, K., Palta, P., Kumar, R. G., et al. (2022) · Brain · doi:10.1093/brain/awac257 · Cited by 87 · see citing works
Self-citationThe A4 study: β ‐amyloid and cognition in 4432 cognitively unimpaired adults
Insel, P. S., Donohue, M., Sperling, R. A., Hansson, O., & Mattsson, N. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51048 · Cited by 81 · see citing works
Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype
Mofrad, R. B., Tijms, B. M., Scheltens, P., Barkhof, F., van der Flier, W. M., Sikkes, S. A. M., & Teunissen, C. E. (2020) · Neurology · doi:10.1212/wnl.0000000000010629 · Cited by 80 · see citing works
Statistical Disease Progression Modeling in Alzheimer Disease
Rakêt, L. L., & Initiative, F. T. A. D. N. (2020) · Frontiers in Big Data · doi:10.3389/fdata.2020.00024 · Cited by 78 · see citing works
Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau
Digma, L. A., Madsen, J. R., Rissman, R. A., Jacobs, D. M., Brewer, J. B., Banks, S. J., Initiative, A. D. N., Weiner, M. W., Aisen, P. S. S., Petersen, R. C., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa025 · Cited by 80 · see citing works
Inferring protein expression changes from mRNA in Alzheimer’s dementia using deep neural networks
Tasaki, S., Xu, J., Avey, D. R., Johnson, L., Petyuk, V., Dawe, R. J., Bennett, D. A., Wang, Y., & Gaiteri, C. (2022) · Nature Communications · doi:10.1038/s41467-022-28280-1 · Cited by 84 · see citing works
Self-citationUnraveling the complexity of human brain: Structure, function in healthy and disease states
Sultana, O. F., Bandaru, M., Islam, M. A., & Reddy, P. H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102414 · Cited by 88 · see citing works
Vascular cognitive impairment – Past, present, and future challenges
Badji, A., Youwakim, J., Cooper, A., Westman, E., & Marseglia, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102042 · Cited by 81 · see citing works
Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging
Vemuri, P., Lesnick, T. G., Knopman, D. S., Przybelski, S. A., Reid, R. I., Mielke, M. M., Graff‐Radford, J., Lowe, V. J., Machulda, M. M., Petersen, R. C., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25600 · Cited by 72 · see citing works
Lewandowski, C. T., Maldonado Weng, J., & LaDu, M. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104811 · Cited by 72 · see citing works
Ginsberg, S. D., Malek-Ahmadi, M., Alldred, M. J., Chen, Y.-H., Chen, K.-W., Chao, M., Counts, S., & Mufson, E. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104540 · Cited by 68 · see citing works
Sex-dependent autosomal effects on clinical progression of Alzheimer’s disease
Fan, C. C., Banks, S. J., Thompson, W. K., Chen, C., McEvoy, L. K., Tan, C. H., Kukull, W. A., Bennett, D. A. A., Farrer, L. A., Mayeux, R. P., et al. (2020) · Brain · doi:10.1093/brain/awaa164 · Cited by 69 · see citing works
Self-citationUdeh-Momoh, C., & Watermeyer, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101459 · Cited by 67 · see citing works
Iulita, M. F., Bejanin, A., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., Barroeta, I., Fernández, S., Altuna, M., Pegueroles, J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad074 · Cited by 68 · see citing works
Sex differences in longitudinal tau-PET in preclinical Alzheimer disease: a meta-analysis
Coughlan, G. T., Klinger, H. M., Boyle, R., Betthauser, T. J., Binette, A. P., Christenson, L., Chadwick, T., Hansson, O., Harrison, T. M., Healy, B., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.0013 · Cited by 69 · see citing works
Role of estrogen in women's Alzheimer's disease risk as modified by APOE
Valencia‐Olvera, A. C., Weng, J. M., Christensen, A., LaDu, M. J., & Pike, C. J. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13209 · Cited by 67 · see citing works
Edwards, L., Joie, R. L., Iaccarino, L., Strom, A., Baker, S. L., Casaletto, K. B., Cobigo, Y., Grant, H. E., Kim, M., Kramer, J. H., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.003 · Cited by 61 · see citing works
Nag, S., & Schneider, J. A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00846-7 · Cited by 65 · see citing works
Self-citationOveisgharan, S., Wang, T., Barnes, L. L., Schneider, J. A., Bennett, D. A., & Buchman, A. S. (2024) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(24)00033-3 · Cited by 61 · see citing works
Self-citationSex differences in mixed neuropathologies in community-dwelling older adults
Barnes, L. L., Lamar, M., & Schneider, J. A. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.028 · Cited by 62 · see citing works
Self-citationVascular pathology and pathogenesis of cognitive impairment and dementia in older adults
Agrawal, S., & Schneider, J. A. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100148 · Cited by 60 · see citing works
Self-citationBelonwu, S., Li, Y., Bunis, D. G., Rao, A. A., Solsberg, C. W., Tang, A., Fragiadakis, G. K., Dubal, D. B., Oskotsky, T., & Sirota, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02591-8 · Cited by 54 · see citing works
Li, J., Zhao, R., Jiang, Y., Xu, Y., Zhao, H., Lyu, X., & Wu, T. (2020) · Food & Function · doi:10.1039/c9fo02103e · Cited by 56 · see citing works
Impact of intestinal disorders on central and peripheral nervous system diseases
El-Hakim, Y., Bake, S., Mani, K. K., & Sohrabji, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105627 · Cited by 54 · see citing works
Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease
Oveisgharan, S., Yang, J., Yu, L., Burba, D., Bang, W., Tasaki, S., Grodstein, F., Wang, Y., Zhao, J., De Jager, P. L., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000206833 · Cited by 53 · see citing works
Self-citationRoberts, J. A., Varma, V. R., An, Y., Varma, S., Candia, J., Fantoni, G., Tiwari, V., Anerillas, C., Williamson, A., Saito, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi8178 · Cited by 49 · see citing works
Self-citationSex influences clinical phenotype in frontotemporal dementia
Pengo, M., Alberici, A., Libri, I., Benussi, A., Gadola, Y., Ashton, N. J., Zetterberg, H., Blennow, K., & Borroni, B. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06185-7 · Cited by 50 · see citing works
Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
Coles, M., Steiner-Lim, G. Z., & Karl, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.962922 · Cited by 51 · see citing works
Sex differences in the genetic architecture of Alzheimer’s disease
Dumitrescu, L., Mayeda, E. R., Sharman, K., Moore, A. M., & Hohman, T. J. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0157-1 · Cited by 48 · see citing works
Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment
Oveisgharan, S., Dawe, R. J., Yu, L., Kapasi, A., Arfanakis, K., Hachinski, V., Schneider, J. A., & Bennett, D. A. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3472 · Cited by 50 · see citing works
Self-citation<i>Tlr7</i> drives sex differences in age- and Alzheimer’s disease–related demyelination
Lopez-Lee, C., Kodama, L., Fan, L., Zhu, D., Zhu, J., Wong, M. Y., Ye, P., Norman, K., Foxe, N. R., Ijaz, L., et al. (2024) · Science · doi:10.1126/science.adk7844 · Cited by 49 · see citing works
Alzheimer’s disease frequency peaks in the tenth decade and is lower afterwards
Farfel, J. M., Yu, L., Boyle, P. A., Leurgans, S. E., Shah, R. C., Schneider, J. A., & Bennett, D. A. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0752-0 · Cited by 46 · see citing works
Self-citationKovács, G. G. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000664 · Cited by 44 · see citing works
Prabha, S., Sajad, M., Hasan, G. M., Islam, A., Hassan, M. I., & Thakur, S. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102476 · Cited by 44 · see citing works
Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions
Wisse, L. E. M., Ravikumar, S., Ittyerah, R., Lim, S., Lane, J., Bedard, M. L., Xie, L., Das, S. R., Schuck, T., Grossman, M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01225-3 · Cited by 42 · see citing works
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01492-x · Cited by 41 · see citing works
Honarpisheh, P., & McCullough, L. D. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14675 · Cited by 38 · see citing works
Cousins, K. A. Q., Phillips, J. S., Irwin, D. J., Lee, E. B., Wolk, D. A., Shaw, L. M. J., Zetterberg, H., Blennow, K., Burke, S., Kinney, N. G., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12233 · Cited by 36 · see citing works
Association of White Matter Hyperintensities With Pathology and Progression of Parkinsonism in Aging
Oveisgharan, S., Yu, L., Poole, V. N., Evia, A. M., Barnes, L. L., Schneider, J. A., Arfanakis, K., Bennett, D. A., & Buchman, A. S. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3996 · Cited by 38 · see citing works
Self-citationEmrani, S., & Sundermann, E. E. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101184 · Cited by 45 · see citing works
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
Cousins, K. A. Q., Irwin, D. J., Wolk, D. A., Lee, E. B., Shaw, L. M. J., Trojanowski, J. Q., Re, F. D., Gibbons, G. S., Grossman, M., & Phillips, J. S. (2020) · Brain · doi:10.1093/brain/awaa165 · Cited by 38 · see citing works
Blanken, A. E., & Nation, D. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200245 · Cited by 37 · see citing works
Interactive rather than independent effect of APOE and sex potentiates tau deposition in women
Wang, Y., Pascoal, T. A., Therriault, J., Kang, M. S., Benedet, A. L., Savard, M., Tissot, C., Lussier, F. Z., Arias, J. F., Mathotaarachchi, S. S., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab126 · Cited by 36 · see citing works
ARTS: A novel In-vivo classifier of arteriolosclerosis for the older adult brain
Makkinejad, N., Evia, A. M., Tamhane, A. A., Javierre‐Petit, C., Leurgans, S. E., Lamar, M., Barnes, L. L., Bennett, D. A., Schneider, J. A., & Arfanakis, K. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102768 · Cited by 35 · see citing works
Self-citationNew Horizon: Exercise and a Focus on Tissue-Brain Crosstalk
Townsend, L. K., MacPherson, R. E. K., & Wright, D. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab333 · Cited by 35 · see citing works
Hulshof, L. A., Frajmund, L. A., van Nuijs, D., van der Heijden, D. C. N., Middeldorp, J., & Hol, E. M. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.12.009 · Cited by 35 · see citing works
Individuals with Alzheimer's disease and low tau burden: Characteristics and implications
Landau, S. M., Lee, J., Murphy, A., Ward, T. J., Harrison, T. M., Baker, S. L., DeCarli, C. S., Harvey, D. J., Tosun, D., Weiner, M. W., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13609 · Cited by 33 · see citing works
Vila‐Castelar, C., Chen, Y., Langella, S., Lopera, F. J., Zetterberg, H., Hansson, O., Dage, J. L., Janelidzde, S., Su, Y., Chen, K., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13314 · Cited by 35 · see citing works
Ohta, Y., Nomura, E., Hatanaka, N., Osakada, Y., Matsumoto, N., Sasaki, R., Tsunoda, K., Takemoto, M., Tadokoro, K., Hishikawa, N., et al. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.08.062 · Cited by 34 · see citing works
Vergallo, A., Houot, M., Cavedo, E., Lemercier, P., Vanmechelen, E., De Vos, A., Habert, M., Potier, M., Dubois, B., Lista, S., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.07.001 · Cited by 32 · see citing works
CSF Alzheimer Disease Biomarkers
Greenberg, B., Pettigrew, C. A., Soldan, A., Wang, J., Wang, M., Darrow, J. A., Albert, M., & Moghekar, A. (2022) · Neurology · doi:10.1212/wnl.0000000000200953 · Cited by 32 · see citing works
Misiura, M. B., Butts, B., Hammerschlag, B., Munkombwe, C., Bird, A., Fyffe, M., Hemphill, A., Dotson, V. M., & Wharton, W. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01408-x · Cited by 29 · see citing works
Cui, S., Jiang, Q., & Chen, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101918 · Cited by 30 · see citing works
A Lifecourse Perspective on Female Sex-Specific Risk Factors for Later Life Cognition
Peterson, A. J., & Tom, S. E. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01133-y · Cited by 32 · see citing works
Nemes, S., Logan, P. E., Manchella, M. K., Mundada, N. S., Joie, R. L., Polsinelli, A. J., Hammers, D. B., Koeppe, R. A., Foroud, T., Nudelman, K. N. H., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13403 · Cited by 29 · see citing works
Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?
Banks, S. J., Andrews, M., Digma, L. A., Madsen, J. R., Reas, E. T., Caldwell, J., McEvoy, L. K., Fan, C. C., Dale, A. M., & Brewer, J. B. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.013 · Cited by 30 · see citing works
Hu, Y., Boonstra, J. T., McGurran, H., Stormmesand, J., Sluiter, A. A., Balesar, R. A., Verwer, R. W. H., Swaab, D. F., & Bao, A. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12729 · Cited by 28 · see citing works
Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner
Dratva, M. A., Banks, S. J., Panizzon, M. S., Galasko, D. R., Sundermann, E. E., & Initiative, A. D. N. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00620-4 · Cited by 30 · see citing works
Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Vila‐Castelar, C., Akinci, M., Palpatzis, E., Dominguez, P. A., Operto, G., Kollmorgen, G., Quijano‐Rubio, C., Blennow, K., Zetterberg, H., Falcón, C., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02753-9 · Cited by 31 · see citing works
Libard, S., & Alafuzoff, I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0748-9 · Cited by 24 · see citing works
Microglial immunometabolism endophenotypes contribute to sex difference in Alzheimer's disease
Hou, Y., Caldwell, J., Lathia, J. D., Leverenz, J. B., Pieper, A. A., Cummings, J. L., & Cheng, F. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13546 · Cited by 27 · see citing works
Zotin, M. C. Z., Makkinejad, N., Schneider, J. A., Arfanakis, K., Charidimou, A., Greenberg, S. M., & van Veluw, S. J. (2023) · Neurology · doi:10.1212/wnl.0000000000207940 · Cited by 29 · see citing works
Self-citationDisease‐specific interactome alterations via epichaperomics: the case for Alzheimer’s disease
Ginsberg, S. D., Neubert, T. A., Sharma, S., Digwal, C. S., Yan, P., Timbus, C., Wang, T., & Chiosis, G. (2021) · FEBS Journal · doi:10.1111/febs.16031 · Cited by 27 · see citing works
Fish, n-3 fatty acids, cognition and dementia risk: not just a fishy tale
Saleh, R. N. M., & Minihane, A. M. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003700 · Cited by 27 · see citing works
Vila‐Castelar, C., Tariot, P. N., Sink, K. M., Clayton, D., Langbaum, J. B. S., Thomas, R. G., Chen, Y., Su, Y., Chen, K., Hu, N., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12552 · Cited by 27 · see citing works
Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults
Oveisgharan, S., Yu, L., Barnes, L. L., Agrawal, S., Schneider, J. A., Bennett, D. A., & Buchman, A. S. (2022) · Neurology · doi:10.1212/wnl.0000000000200182 · Cited by 27 · see citing works
Self-citationSex Differences in Onset and Progression of Cerebral Amyloid Angiopathy
Koemans, E. A., Castello, J. P., Rasing, I., Abramson, J. R., Voigt, S., Perosa, V., van Harten, T. W., van Zwet, E. W., Terwindt, G. M., Gurol, M. E., et al. (2023) · Stroke · doi:10.1161/strokeaha.122.040823 · Cited by 28 · see citing works
Sex and Sleep Disruption as Contributing Factors in Alzheimer’s Disease
Johnson, C. E., Duncan, M. J., & Murphy, M. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230527 · Cited by 34 · see citing works
Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal
McCarter, S. J., Lesnick, T. G., Lowe, V. J., Mielke, M. M., Constantopoulos, E., Rabinstein, A. A., Przybelski, S. A., Botha, H., Jones, D. T., Ramanan, V. K., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012770 · Cited by 26 · see citing works
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
Tallon, C., Bell, B. J., Sharma, A., Pal, A., Malvankar, M. M., Thomas, A. G., Yoo, S., Hollinger, K. R., Coleman, K., Wilkinson, E. L., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102066 · Cited by 26 · see citing works
Strefeler, A., Jan, M., Quadroni, M., Teav, T., Rosenberg, N., Chatton, J., Guex, N., Gallart‐Ayala, H., & Ivanišević, J. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01162-4 · Cited by 26 · see citing works
Sex differences in a murine model of Cerebral Amyloid Angiopathy
Maniskas, M. E., Mack, A. F., Morales‐Scheihing, D., Finger, C. E., Zhu, L., Paulter, R., Urayama, A., McCullough, L. D., & Manwani, B. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100260 · Cited by 25 · see citing works
Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease
Wisse, L. E. M., Wuestefeld, A., Murray, M. E., Jagust, W. J., & Joie, R. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14582 · Cited by 24 · see citing works
Bergamino, M., Keeling, E. G., Baxter, L. C., Sisco, N. J., Walsh, R. R., & Stokes, A. M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210406 · Cited by 26 · see citing works
Dementias Among Older Males and Females in the U.S. Medicare System With and Without HIV
Yu, X., Kuo, Y., Raji, M. A., Berenson, A. B., Baillargeon, J., & Giordano, T. P. (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003184 · Cited by 24 · see citing works
Nature and implications of sex differences in AD pathology
Babapour Mofrad, R., & van der Flier, W. M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0115-7 · Cited by 24 · see citing works
Oveisgharan, S., Kim, N., Agrawal, S., Yu, L., Leurgans, S. E., Kapasi, A., Arfanakis, K., Bennett, D. A., Schneider, J. A., & Buchman, A. S. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02527-z · Cited by 24 · see citing works
Self-citationBonkhoff, A. K., Coughlan, G., Perosa, V., Alhadid, K., Schirmer, M. D., Regenhardt, R. W., van Veluw, S. J., Buckley, R. F., Fox, M., & Rost, N. S. (2025) · Science Advances · doi:10.1126/sciadv.adt9243 · Cited by 25 · see citing works
- Authors
- Oveisgharan, S., Arvanitakis, Z., Yu, L., Farfel, J., Schneider, J. A., & Bennett, D. A.
- Affiliations
- Rush University Medical Center (US)
- Corresponding author
- Oveisgharan, Shahram
- Venue
- Acta Neuropathologica
- Published
- 2018-10-17
- Volume
- 136
- Issue
- 6
- Pages
- 887-900
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC6279593
- OpenAlex
- W2897712355
- Semantic Scholar
- 1ad7c3913ad11214ddf4ab763a09c0c3f7cd5c6f
- Cited by
- 330
- References
- 67
- Citations by year
- 2026: 37 · 2025: 69 · 2024: 43 · 2023: 47 · 2022: 44 · 2021: 42 · 2020: 23 · 2019: 23 · 2018: 2
- FWCI
- 15.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health (R01AG17917, P30AG10161, RO1NS084965, R01AG15819)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Keywords
- Alzheimer's disease, sex differences, tau tangles, amyloid-beta, arteriolosclerosis, cerebral amyloid angiopathy, Lewy bodies, TDP-43, hippocampal sclerosis, cerebral infarction, atherosclerosis, postmortem brain examination, Religious Orders Study, Rush Memory and Aging Project
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Autopsy, Brain, Cross-Sectional Studies, DNA-Binding Proteins, Female, Humans, Longitudinal Studies, Male, Sex Characteristics, Chi-Square Distribution, tau Proteins, Arteriolosclerosis, alpha-Synuclein, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-18.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-18.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review